News & Analysis on Clinical Trial Services & Contract Research And Development
Scientists have created the nanotechnology equivalent of a Trojan horse to smuggle a powerful chemotherapeutic drug inside tumour cells - increasing the drug's cancer-killing activity and reducing its toxic side effects.
The Supreme Court's decision to allow drug companies to receive exemptions from patent infringement during key early-stage research carries wider significance throughout the industry as it reduces licence negotiation for patented inventions or...
UK-headquartered Invensys has divested its stake in the Israeli joint venture Foxboro NMR, which focuses the application of nuclear magnetic resonance imaging technology in the process industries.
Niro Phama Systems and Courtoy have developed a new module for their range of tablet presses that solves a control dilemma that has faced the pharmaceutical industry ever since automated tablet presses came into use.
Solutia has drawn up an agreement with former parent Monsanto that could finally bring it out of the state of bankruptcy reorganisation it has resided in since the end of 2003, reports Phil Taylor.
Kreatech Biotechnology launches a series of array-based labelling kits for genomic DNA for microarray based comparative genomic hybridisation analysis, offering a one-step procedure that does not require the need for amplification.
Delphi Medical Systems Corporation has entered into an outsourcing contract with Applied Biosystems in a move that adds a life science instrumentation manufacturing facility to its operations portfolio.
India's Malladi Drugs and Pharmaceuticals has acquired a US company to boost its presence in the market for pseudoephedrine, an ingredient used in cough and cold preparations, reports Phil Taylor.